WELCOME TO THE FUTURE OF ENHANCED RECOVERY AFTER SURGERY (ERAS®) FOR PANCREATIC SURGERY
We are excited to announce a significant update to the ERAS® Interactive Audit System (EIAS), aligning with the latest published ERAS® Society guidelines on pancreatic surgery.
INTRODUCING THE UPDATED PANCREAS PROTOCOL IN EIAS
The ERAS® Interactive Audit System, a cornerstone for ERAS® implementation, now includes an upgraded pancreas protocol.
This protocol is designed to reflect the latest ERAS® Society guidelines.
Our commitment to evidence-based care is stronger than ever, ensuring that healthcare providers have access to the most current guidelines for Enhanced Recovery After Surgery.
KEY BENEFITS OF ERAS® WITHIN PANCREATIC SURGERY
- Reduced Complications and Mortality: The adoption of ERAS® guidelines leads to improved patient outcomes by utilizing the best practices in surgical care.[1, 5, 6]
- Reduced Length of Stay: Efficient care processes under ERAS® protocols facilitate swift patient recovery, reducing the time spent in hospitals.[1, 4]
- Significant Cost Savings: Shorter Length of Stay results in lower costs for healthcare facilities.[1, 2, 3]
WHY OPT FOR THE ERAS® INTERACTIVE AUDIT SYSTEM?
Choosing to implement ERAS® through Encare’s EIAS (ERAS® Interactive Audit System) and EIP (ERAS® Implementation Program) means adopting a system that’s specifically built for the implementation and auditing of and research within ERAS® .
Users of EIAS have consistently reported higher compliance with ERAS® guidelines, resulting in fewer complications, reduced hospital stays, and substantial cost savings.
SPREAD THE WORD AND EXPERIENCE EIAS FIRSTHAND
We encourage pancreatic surgeons and their teams to explore these updates and embark on their ERAS® journey.
We are offering personalized demos to introduce you to the new features of the ERAS® Interactive Audit System.
Book your slot now for a hands-on experience and expert consultation on implementing ERAS® in your practice.
CONCLUSION
The ERAS® Interactive Audit System, with its updated pancreas protocol, is an opportunity for medical professionals to elevate the standard of care in pancreatic surgery, aligning with the latest ERAS® Society guidelines.
REFERENCES:
- Takagi K, Yoshida R, Yagi T, Umeda Y, Nobuoka D, Kuise T, Hinotsu S, Matsusaki T, Morimatsu H, Eguchi J, Wada J, Senda M, Fujiwara T. Effect of an enhanced recovery after surgery protocol in patients undergoing pancreaticoduodenectomy: A randomized controlled trial. Clin Nutr. 2019 Feb;38(1):174-181. doi: 10.1016/j.clnu.2018.01.002. Epub 2018 Jan 9. PMID: 29373148.
- Joliat GR, Labgaa I, Petermann D, Hübner M, Griesser AC, Demartines N, Schäfer M. Cost-benefit analysis of an enhanced recovery protocol for pancreaticoduodenectomy. Br J Surg. 2015 Dec;102(13):1676-83. doi: 10.1002/bjs.9957. Epub 2015 Oct 22. PMID: 26492489.
- Lof S, Benedetti Cacciaguerra A, Aljarrah R, Okorocha C, Jaber B, Shamali A, Clarke H, Armstrong T, Takhar A, Hamady Z, Abu Hilal M. Implementation of enhanced recovery after surgery for pancreatoduodenectomy increases the proportion of patients achieving textbook outcome: A retrospective cohort study. Pancreatology. 2020 Jul;20(5):976-983. doi: 10.1016/j.pan.2020.05.018. Epub 2020 May 28. PMID: 32600854.
- Jesse K. et al The impact of intraoperative goal-directed fluid therapy on complications after pancreaticoduodenectomy, Annals of Medicine and Surgery, Volume 36, 2018,, Pages 23-28,ISSN 2049-0801, https://doi.org/10.1016/j.amsu.2018.10.018.
- Wang XY, Cai JP, Huang CS, Huang XT, Yin XY. Impact of enhanced recovery after surgery protocol on pancreaticoduodenectomy: a meta-analysis of non-randomized and randomized controlled trials. HPB (Oxford). 2020 Oct;22(10):1373-1383. doi: 10.1016/j.hpb.2020.07.001. Epub 2020 Aug 15. PMID: 32811766.
- Dai J, Jiang Y, Fu D. Reducing postoperative complications and improving clinical outcome: Enhanced recovery after surgery in pancreaticoduodenectomy – A retrospective cohort study. Int J Surg. 2017 Mar;39:176-181. doi: 10.1016/j.ijsu.2017.01.089. Epub 2017 Jan 26. PMID: 28132917.
